




Otitis media (OM) is one of the most common infections diagnosed in young children around the world. Approximately $5.0 billion is spent annually on healthcare costs related to OM. Studies have shown OM to be highly prevalent (near 100%) in individuals with orofacial clefts (OC). OCs are the most common craniofacial birth defect in the world with approximately one in 500 to 1000 live births being affected. The medical costs for corrective surgeries alone pose a significant public health problem. These two conditions combined create a significant burden on the health, quality of life, and socioeconomic well-being of those affected and their family members. 
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Approximately one in every 500 to 1000 live births is affected with an orofacial cleft (OC), making OC’s a relatively common birth defect (Fogh-Andersen 1942; Woolf et al. 1963; 1964; Wyszynski et al. 1996; Croen et al. 1998; Weinberg, 2007a; 2007b; Dixon et al. 2011; Kohli et al. 2011; Yaqoob et al. 2013). Worldwide, orofacial clefts are the most common craniofacial birth defect. The significant number of affected individuals as well as the substantial cost to repair OCs represents a major public health problem. The extensive surgeries required to repair the cleft place a substantial financial burden on the health care system (Weinberg, 2007a). Multiple surgeries are required depending on the severity of the cleft and the extent of the craniofacial abnormalities. The surgeries are expensive, painful, time consuming, and emotionally draining for families and have the potential to create rifts within the family unit. Additionally, these children are susceptible to having feeding complications, require hearing and speech therapy, orthodontic treatment, otolaryngology treatment, psychosocial counseling, and treatment for recurring ear infections (Nemana et al. 1992; Neiswanger et al. 2002; Weinberg, 2006; 2007a; 2007b; Mossey et al. 2009; May, 2011). Neonates with an OC have increased infant mortality and morbidity compared to unaffected children, especially for those in developing countries with limited care options for individuals with an OC (Dixon et al. 2011). 
The vast majority of OCs are isolated and are not present as part of a syndrome. Non-syndromic orofacial clefts (NSOC) account for approximately 75% of affected cases, while approximately 25% are considered syndromic (Weinberg, 2007a). While syndromic cleft cases are typically due to specific mutations or chromosomal abnormalities, identifying the genetic basis for NSOCs has been much more difficult due to the complex etiology (Woolf et al. 1963; Fraser 1970; Spirtz, 2001; Wyszynski et al. 1996; Weinberg, 2007a; Mossey, et al. 2009; Dixon et al. 2011; Kohli et al. 2012; Shkoukani et al, 2013; Yaqoob et al. 2013). For families with an affected child, the chance of recurrence is often a major concern. Doctors and genetic counselors quote an empirical recurrence risk depending on the type of cleft and the family history. However, research has shown that the general population recurrence risk may not apply to all families (Weinberg, 2007a). For some families a more accurate risk number can be determined based on specific phenotypic craniofacial abnormalities shared within families. Previous studies suggest that those with an NSOC and their unaffected relatives have related physical characteristics, which differ from the general population (Weinberg, et al. 2006; 2007a; 2007b; Marazita, 2012). 
OCs – especially those where the hard palate is affected, have a much greater risk of chronic otitis media (Paradise, 1969; Bluestone, 1971; 1972a; 1972b; 1975; 2004; Doyle et al. 1980; Shibahara et al. 1988Matsune et al. 1991a; 1991b; Daly et al. 2000; Sheahan et al. 2003; Lieberthal, 2006; Flynn et al. 2009; Sheer et al. 2010;). Otitis media is defined as an infection in the middle ear and is a common occurrence in the general population. The majority of children have at least one episode of otitis media, with 50-85% of children affected before the age of three (Doyle et al. 1980; Daly et al. 2000; Flynn et al. 2009). Approximately 10-20% of children under the age of one have recurrent otitis media, defined as three or more episodes, and nearly 40% of older children have six or more otitis media episodes in their lifetime (Sheahan, 2003). With over 2.2 million cases of otitis media diagnosed each year in the United States and costing $4.0 billion annually, otitis media is a major public health concern (Kemaloglu et al. 2000; Sheahan, 2003). While children without OCs may require eustachian tube placement if the infection persists or occurs multiple times in a short period of time, nearly all children with isolated cleft palate (CP) have chronic otitis media and require eustachian tube placement. Children without a surgical repair of the palate can develop otitis media well into adulthood. Once a child has a repaired palate, their risk of developing chronic otitis media drops to that of the general population (Paradise, 1969; Bluestone, 1971; 1972a; 1972b; 1975; 2004; Doyle et al. 1980; Shibahara et al. 1988; Matsune et al. 1991a; 1991b; Daly et al. 2000; Sheahan et al. 2003; Lieberthal, 2006; Flynn et al. 2009; Sheer et al. 2010). 
The high incidence of otitis media in those affected with OCs can be explained by the anatomical disruption of the palatal shelves, which subsequently disrupts the position and orientation of the eustachian tubes thereby inhibiting proper drainage (Bluestone, 1971; 1975; Shibahara et al. 1988; Siegel et al. 1988; Sadler-Kimes et al. 1989; Takasaki et al. 2000; Sheahan et al. 2003; Bluestone, 2004). Although a visible cleft may not be present, there is evidence that the palatal configuration in the parents and siblings of OC cases may also be abnormal. Such minor abnormalities are hypothesized to represent a sub-clinical phenotypic manifestation of an underlying genetic predisposition (Allen et al. 2014). Because the palate may be abnormal, these unaffected relatives may be at elevated risk for eustachian tube dysfunction. To date, however, there are no data on the incidence of otitis media in the ostensibly unaffected family members of individuals with OCs. 
2.0 	clefting and otitis media
2.1	overview of otitis media
It is estimated that the United States spends over $5 billion in healthcare for otitis media in children (Gould et al., 2010; Allen et al. 2014). Over 90% of children up to age 5 have experienced at least one occurrence of otitis media (Daly and Giebink, 2000; Bluestone, 2004; Lieberthal, 2006; Allen et al. 2014). However, otitis media may be under reported because the only way to establish a diagnosis with any certainty is using the pneumatic otoscope with visualization of the tympanic membrane with identification of a middle-ear effusion and inflammatory changes (Bluestone, 2004; Lieberthal, 2006). Those of a lower socioeconomic status may not have access to the healthcare system; therefore, the otitis media in these children may resolve on its own without medical intervention (Daly et al. 2000). The World Health Organization (WHO, 1996) defines a major public health problem “requiring urgent attention” as prevalence greater than 4%, the WHO reports the prevalence of OM worldwide ranges from 1% to 46% in disadvantaged areas. 





Figure 1: Eustachian tube difference in children and adults.
The adult Eustachian tube has a steeper angle than the child’s does. The steeper angle allows for easier drainage. The lack of drainage in a child’s ear is a major cause of otitis media.*

Like NSOC, otitis media is considered a multifactorial disease. Allen et al. (2014) reviewed research for the evidence for a genetic contribution to otitis media. Family studies have shown heritability estimates as high as 74% (Allen et al. 2014). These studies provided the framework for genome-wide studies in search of specific genes/regions associated with otitis media. The majority of these genes are involved in the inflammatory and immune response. So far, tentative associations have been reported with TLR4, MUC5B, SMAD2, SMAD4 (Allen et al. 2014). Family-based designs for linkage studies with siblings (pairs and larger sibships), nuclear families, and extended pedigrees have provided further insights (Allen et al. 2014). 
Regardless of the cause, there are numerous treatment options available for those suffering from otitis media. Bluestone (2004), reviews, in depth, the different treatment options, which are beyond the scope of this document. Typically, treatment involves a course of systemic antibiotic (most commonly amoxicillin), which has shown to be effective not only as a treatment, but prophylactically as well. Surgical options have increased four-fold between 1970-1990 (Daly et al. 2000). Bluestone (2004) provides evidence for myringotomy and tympanostomy tube placement as providing the best treatment for those where surgical options are warranted. However, it seems that antibiotic in conjunction with surgical repair is the best option for most individuals.
2.2	prevalence of otitis media in clefting
Since 1969 when Paradise published his paper “Diagnosis and management of ear disease in cleft palate infants,” it has been accepted that otitis media is a common occurrence in cases of orofacial clefting (Paradise, 1969). He reported that cleft cases with a palatal involvement were at much greater risk for developing otitis media compared to cases where the cleft involved only the lip. Paradise suggested that all infants with a cleft involving the secondary palate undergo routine otologic evaluation and have tubes placed as soon as possible to prevent otitis media. Many studies since Paradise have looked at the incidence of otitis media in relation to orofacial clefting. Sheahan et al. (2003) reported otitis media rate of 68% in CP patients, with a 45% recurrence rate, while there was an otitis media rate of 76% in CLP patients with a 46% recurrence risk. Suggesting a high rate of otitis media in patients affected with a cleft of the secondary palate; however, this rate is not nearly as high as Paradise’s ~100% incidence of OM reported in 1969. Bluestone (1971), found that 78% of infants with CP required tubes for the treatment of their otitis media, with a higher rate of otitis media without tube placement, stating the probability of all infants with cleft palate having middle ear disease at, or shortly after, birth. He later states the “universal incidence” of a middle-ear effusion in patients with unrepaired cleft palate (Bluestone, 2004). Further evidence suggests a 74.7% prevalence of otitis media in the unilateral CLP population (Flynn et al. 2009). Though not all of these percentages agree, there is one evident fact – there is a high prevalence of otitis media in those affected with a cleft of the secondary palate.
Further studies on the topic by Bluestone (2004) suggest a reason for the high prevalence of otitis media in clefting. There are seven known abnormalities in the structure of the eustachian tube in cleft patients: shorter length of the tube, larger angle between cartilage and tensor veli palatine muscle, greater cartilage cell density, smaller ratio of lateral and medial laminae area of cartilage, less curvature of lumen, less elastin at hinge portion of cartilage, and less insertion ratio of tensor veli palatini to cartilage (Siegel et al. 1988; Shibahara et al. 1988; Sadler-Kimes et al. 1989; Sando and Takahashi, 1990; Matsune et al. 1991a; 1991b; Takasaki et al. 2000). These differences help to illuminate the malformations of the eustachian tube caused by clefts, and the subsequent high rate of otitis media. The eustachian tube is part of a system of structures (palate, nasal cavities, nasopharynx, middle-ear, mastoid gas cell system). The function of the eustachian tube is to regulate the pressure in the middle ear, protect the middle ear from nasopharynx secretions, and drainage of middle-ear secretions into the nasopharynx. If the tube is too open or too closed, then there is abnormal pressure, which can cause an ear infection. Those with a cleft palate have a constricted eustachian tube, which impairs the normal drainage mechanism of the ear. If the tube cannot be opened to drain, then viruses or bacteria can remain within the tube causing major ear infections (Bluestone et al. 1972a; 1972b; 1975; 1980; 2004; Doyle et al. 1980a; 1980b; 1982; 1986).
Although the increased incidence of otitis media is well established in clefts involving the secondary palate (CP and CLP), far fewer studies have investigated clefts involving only the primary palate. Paradise (1969), initially reported a 96% rate for those with secondary palate involvement, while those with only CL reported a 17% rate of otitis media and controls having a 20% rate of otitis media. It is interesting that his results showed that the rate of otitis media was actually less than in the control population, but he did have a small sample size of 12 CL probands. Sheahan (2003) corroborates Paradise’s data with a 16% rate of otitis media in their CL population compared to the 68% and 76% reported in their CP and CLP population, respectively. The highest rate of otitis media reported is Deelder et al. (2011); they found that 33% of CL cases in their study reported an episode of otitis media. These results suggest that, while the rate of infection is much lower than for clefts involving the secondary palate, there is at least a subset of CL cases where the palatal and/or eustachian tube anatomy may be compromised and are therefore susceptible to otitis media. Such findings could affect how CL cases are classified, with implications for treatment, recurrence estimation, and gene identification. It is interesting to note that all of these studies mentioned were performed in either America or European nations. To date there is no worldwide data on the prevalence of OM in CL/P. 
3.0 	OROFACIAL CLEFTING
3.1	CLASSIFICATION AND PHENOTYPIC VARIABILITY
The classification of OCs has been proposed in a variety of different ways. There are several classification schemes based on anatomical location (Fogh-Andersen, 1942; Millard, 1976; Weinberg, 2007a). Clefts can be limited to the primary palate, which includes the lip and alveolus (CL or CL/A). There can also be clefts involving both the primary and secondary palate (CLP) and clefts involving only structures posterior to the incisive suture, which includes the soft palate (CP). When any form of clefting involves the primary palate, it can be either unilateral or bilateral.
Clefts can also be classified according to etiology. OCs can be part of a syndrome caused by single-gene mutations, chromosomal abnormalities, or teratogen exposures. However, the majority of OCs are nonsyndromic; they do not occur as part of a recognized syndrome and are present in the absence of additional malformations. NSOCs do not follow a simple (Mendelian) inheritance pattern and are considered complex genetic traits. Based on recurrence data, nonsyndromic CL and CLP are typically considered etiologically similar and part of the same phenotypic spectrum; together they are referred to as cleft lip with or without cleft palate (CL/P). Nonsyndromic CP is considered etiologically distinct. Murray (2002) reports that over 70% of all CL/P cases are nonsyndromic, while approximately 50% of CP cases are considered nonsyndromic. This investigation focuses exclusively on nonsyndromic clefting (CL, CP, CLP).
3.2	EMBRYOLOGY













The skeletal and other connective tissues of the face are derived from neural crest derived mesenchyme (Grahm, 2003), while the facial musculature is derived from the cranial paraxial mesoderm (Noden et al. 2006). The epithelium of the face is derived from the surface covering the facial prominences, the ectoderm. Development of the face occurs when key genes are activated signaling the different tissues to interact (e.g. Bmp4) (Francis-West et al. 1998; Richman et al. 2003; Jiang, 2006; Parada et al. 2012). For the face to form properly, the process described above requires careful arrangement of multiple proteins to mediate the tasks of the bilateral symmetric cell migration, differentiation, growth, and apoptosis (May, 2011). An error in any part of this process can lead to partial or complete failure of the paired structures causing a cleft. There are a variety of cleft configurations described to date, ranging from a slight cleft of the lip to a complete bilateral cleft of the lip and palate (Figure 2). Each cleft type is dependent on the protein error, which causes a specific part of the process to be affected (Cohen, 2006; Mossey et al. 2009; May, 2011).


Figure 3: The variety of cleft configurations (non-syndromic).
A. Incomplete Cleft Lip; B. Unilateral Complete Cleft Lip; C. Complete Bilateral Cleft Lip; 
D. Cleft Palate Only; E. Unilateral Cleft Lip and Palate; F. Bilateral Cleft Lip and Palate**
3.3	Global EPIDEMIOLoGY
Orofacial clefts are among the most common birth defects worldwide. Approximately one in every 500 to 1000 live births is affected (Fogh-Andersen, 1942; Woolf et al. 1963; 1964; Wyszynski et al., 1996; Croen et al. 1998; Weinberg, 2007a; 2007b; Dixon et al. 2011; Kohli et al. 2011; Yaqoob et al, 2013). In general, CL/P occurs more frequently than CP. The frequency of CLP also differs by sex with a 2:1 male to female ratio for clefts involving the lip and a 1:2 male to female ratio for cleft palate only. Furthermore, there is a 2:1 ratio of left to right sided clefts in unilateral cases (Dixon et al. 2011). 
There is also ethnic variation in incidence. Croen et al. (1998) performed a study in California with 2,000 individuals with NSOCs of different ethnic populations demonstrating an incidence of 1.5-2 for every 1,000 live births. The incidence of clefting varied by population: White, Native American, African American, Hispanics, Japanese, and Chinese. The prevalence of CL/P was highest in Native Americans, then Whites, Japanese, Chinese, and African Americans. A similar ranking was found among the CP patients with Native American’s again having the highest rate, followed by Whites, Hispanics, and African Americans. This study shows that although clefting is found worldwide, there are different ethnicities that show a higher incidence, which could suggest a genetic cause.  
3.4	Genetic ETIOLOGY
CL/P and CP are complex genetic traits. They are often referred to as multifactorial, meaning there are multiple genetic and non-genetic (environmental) factors that can contribute to cleft susceptibility. Multifactorial diseases, or in this case birth defects, are complex due to the lack of a simple inheritance pattern. There is no defining Mendelian inheritance pattern (e.g., autosomal recessive or autosomal dominant) for complex disease traits, making it more difficult to predict the probability of passing on such a trait to the next generation. Multifactorial traits possess the same complexities as Mendelian diseases, such as: heterogeneity, variable expressivity, phenocopies, and reduced penetrance. Added to this are the complications of additive and/or multiplicative gene-gene and gene-environment interactions. Together, all of these factors make the etiologies of complex traits difficult to determine, and since many diseases are complex, it is challenging to find causes for some of our most common health conditions (Weinberg, 2007a; Yaqoob et al. 2013).
The work by Fogh-Andersen (1942) thoroughly summarized hereditary cases of clefts in the 1920-1940s. Some researchers suggested an autosomal dominant inheritance, other suggested recessive; some researchers determined the trait was sex-linked, while others showed incomplete dominant inheritance patterns within families. Furthermore, by studying these cases, Fogh-Andersen was the first to distinguish between CL/P and CP, suggesting not only that most cases of CL/P were genetic, but that they were dominant sex-limiting to males. By the early 1960’s, multifactorial patterns of inheritance were being developed and were immediately applied to CL/P (Woolf et al. 1963; 1964; Fraser, 1970; 1976; Carter et al. 1982; Hu et al. 1982; Weinberg, 2007a). By studying different models (e.g., multifactorial threshold theory, segregation analysis, goodness-to-fit approaches) it seemed that CL/P fit no distinct pattern, although there was evidence for every model, there was no exact fit (reviewed in Weinberg, 2007a). Families seemed to show a higher recurrence risk of producing a child with a cleft if a previous child was born with a cleft compared to the general population (Wyszynski et al. 1996). Therefore, familial patterns of recurrence were studied to determine the genetic basis of clefting (Weinberg, 2007a). These studies showed the recurrence risk for first-degree relatives is around 4% - 40 times greater than the general population - with the recurrence increasing as more individuals in a family are affected (Mitchell et al. 1993). 
Many years of research have scrutinized CL/P families for a definitive genetic cause. In that time there are a number of different genes known to cause orofacial cleft syndromes, such as: Kabuki syndrome, Oral-facial-digital syndrome, chromosomal aberrations (such as translocations) (Yagoob, 2013), Apert syndrome, Van der Woude syndrome, CL/P ectodermal dysplasia syndrome, Crouzon syndrome, Pierre Robin syndrome, Treacher Collins syndrome,  (Kohli et al. 2012), and many more. However, a definitive genetic cause for the vast majority of NSOCs has not been identified. Candidate genes or loci have been the major focus for research in this discipline. Kohli et al. (2012), review the candidate genes found to date thought to be linked to NSOCs. Transforming growth factor-alpha (TGFA) is one such gene that has demonstrated a mixture of results, suggesting that certain mutations in this gene could be etiological to clefts, while others suggest that certain variants (TaqI C2 allele) together with maternal smoking and/or lack of prenatal vitamins in the first trimester increases the risk for a fetus to develop a cleft. The Drosophila msx homeobox homolog-1 (MSX1) gene was first found to cause autosomal dominant tooth agenesis and concurrent presence of CL/P. It has been suggested that MSX1 mutations contribute to approximately 2% of all nonsyndromic CL/P (Jezewski et al. 2003). The enzyme 5,10-Methylenetetrahydrofolate reductase (MTHFR) is an important catalyst in the folate metabolism pathway. The MTHFR C677T single-nucleotide polymorphism (SNP) is a risk factor for neural tube defects and an increased risk for CLP (up to 10 times the general population risk). The gene transforming growth factor-beta-3 (TGFB3) is important in the adhesion of the opposing palatal shelves during face formation. The IVS5+104 A>G SNP was recently found to increase the risk of CL/P in the Korean population by as much as 16 times. There are many other candidate genes being researched, a review of all of these genes is beyond the scope of this paper.
	In addition to genetic causes, there are wide varieties of environmental factors causing CL/P. Several of these are related to teratogenic and maternal health factors. A teratogen is defined as any substance that can cause malformations in a developing fetus (Wilson et al. 1977). There are several drugs known to cause a teratogenic effect (causing a cleft) when taken during the first eight weeks of pregnancy, such as: hydantoin, sodium valproate, trimethadion, tranquilizers (Yaqoob et al. 2013), anti-convulsants (Abrishamchian et al. 1994), benzodiazepines (Dolovich et al. 1998), folate antagonists (Hernandez-Diaz et al. 2000), maternal smoking (Wyszynski et al. 1997), and alcohol (Munger et al. 1996; Kohliet al. 2012; Yaqoob et al. 2013). Each of these drugs has an effect on the developing fetus, typically in a dose-dependent manner (Shaw et al. 1999; Chung et al. 2000). Other teratogens such as toxins (organic solvents, and pesticides), as well as maternal infections associated with fever may be related to isolated clefts. Factors associated with maternal health have also been shown to play a role in cleft development (Hayes, 2002; Shashi et al. 2002; Weinberg, 2007a; Yaqoob et al. 2013). In animal studies, deficiencies in vitamins A, various B vitamins, and folic acid, have consistently been shown to result in OCs (Munger, 2002). Mothers suffering from diabetes mellitus or phenylketonuria are at higher risk of having a child with an OC (Weinberg, 2007a; Kohli et al. 2012; Yaqoob et al. 2013).
4.0 	Intervention
The CL/P and general populations both experience OM. As stated earlier, over $5 billion are spent annually in the United States on OM related medical expenses. Add to these expenses the medical costs of having a child with a CL/P, the combined medical problems pose a significant public health problem worldwide. Treatment for OM centers around medication and/or surgeries after the infection has been diagnosed. Since OM is such a major health concern worldwide, it is probable that a public health intervention could be devised in order to prevent an infection. 
Surgeries for eustachian tubes have increased in frequency over the last several decades. Therefore, it seems the most reasonable thought for an intervention – prophylactic placement of eustachian tubes in all infants born with a CL/P. However, there are a wide variety of problems that should be addressed prior to prophylactic surgeries. While the surgery for eustachian tube placement is done on a regular basis for children who require them, it is still a surgery with risks involved. There are also risks with the tubes not working to help the child clear an infection, there is a chance the tubes migrate out of the ear, and many more complications. Furthermore, since CL/P children have so many OMs at such young ages, the intervention would need to take place in infancy. Due to the complications of performing surgeries on the infant population, it may be safer for the patient population to develop an intervention targeting the actual cause of the infections and use medication rather than surgery to prevent OM in this high-risk population.
Research has shown a wide variety of viruses and bacteria causing the OM infections, one of the most common is streptococcus pneumoniae (Berman, 1995; Nuorti, et al. 2010; Durando, et al. 2013). The appropriate antibiotic therapy can reduce the burden of disease, therefore, a vaccine targeting the more common causes for OM would greatly decrease the public health burden around the world. Berman (1995) reviewed the extent of OM impact in developing countries, reviewed the many different pathogens found to cause OM, and suggests research into the efficacy of a conjugated pneumococcal vaccine to prevent OM. Since this evaluation, the CDC and other researchers have investigated the aforementioned vaccine. This vaccine was initially developed over one hundred years ago in 1911 and has since been improved upon (Durando, et al. 2013). The 13-valent pneumococcal polysaccharide-protein conjugate vaccine (PCV13) was developed and approved by the FDA in 2010 for the prevention of pneumococcal disease among infants and young children. This vaccine can be given to children as young as 6 weeks to 71 months of age as a 4-dose series (Nuorti, et al. 2010). Prior PCV vaccinations have reduced the OM caused by Streptococcus pneumoniae by 34%, with an overall decrease in OM of 6-7% in developed nations such as Finland. Furthermore, the same study showed a 9% decrease in frequent OM and a 20% reduction in tube placement surgeries in the population (Black, et al. 2000). Other research studies have also shown the decrease in OM in developed countries. However, this vaccine is not available in underdeveloped nations, such as India, Uganda, Nigeria, etc. Further research is required to determine the efficacy of this treatment in underdeveloped countries. 

4.1	Future Research
The burden of disease is still incredibly high from this infection in developed nations where the PCV vaccine is available with a high rate of successful compliance. However, in developing nations, it is yet to be seen if the compliance of the population would demonstrate a high herd immunity to justify this vaccination. Furthermore, the price of this vaccine for developing countries may inhibit the population from receiving the vaccination and may prevent the governments from offering the vaccine all together. Since OM is so common in the general population, further research is required to find a PCV vaccine that decreases the rate of OM in the general population more than 6-7%. In developed countries there are PCV vaccines that supplement the current standard vaccination for high risk groups (such as those with a CL/P). This PPSV23 (23-valent pneumococcal polysaccharide vaccine) has not decreased the rate of OM over the general vaccination (Nuorti, et al. 2010). Research into the lack of improvement between the PPSV23 and PCV vaccinations may provide insight into another type of vaccination that may increase the efficacy of current vaccinations in preventing OM.
4.2	Conclusion
In conclusion, the high rate of OM in the CL/P population is a worldwide public health concern. Interventions to prevent OM in the general population have shown little success. Prophylactic surgery would not be the best option for the general population, but perhaps in cases where there is an extreme cause of clefting prophylactic eustachian tube placement should be considered. There are a variety of concerns when operating on an infant, but the pain and financial burden on the patient and family members may outweigh the risk of this operation. Vaccinations have been developed and provided in developed countries for the last century with little success in decreasing OM in the general population. More advanced vaccines have been provided for high-risk populations (such as the CL/P population) but show no decrease in OM and would not be the best intervention for the CL/P population.
4.3	Recommendation
This researcher believes that a combination of the vaccinations and prophylactic tube placement is the best course of action for the CL/P population. Prophylactic tube placement in the first weeks of life should prevent an initial infection. After the CL/P surgeries are completed the tubes may be removed, as the child is at the general population risk for OM and should have received a full course of the PCV vaccinations prior to the completion of the multiple surgeries. While surgeries are dangerous, especially on infants, the benefits outweigh the risk because of the decreased burden of an additional medial problem on top of the CL/P issues faced by these families. 
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Figure 2: Face configuration on day 45 of development.
A. Frontonasal Prominence; B. Right Maxillary Prominence; C. Right Mandibular Prominence; D. Left Maxillary Prominence; E. Left Mandibular Prominence
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